A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 11, Issue 4, Pages 378-387
Publisher
Springer Nature
Online
2016-01-19
DOI
10.1038/nnano.2015.311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines
- (2015) Jonathan P. Celli et al. LASERS IN SURGERY AND MEDICINE
- Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
- (2014) M T Huggett et al. BRITISH JOURNAL OF CANCER
- Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates
- (2014) B. Q. Spring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Porphyrin–phospholipid liposomes permeabilized by near-infrared light
- (2014) Kevin A. Carter et al. Nature Communications
- Inhibition of c-Met Reduces Lymphatic Metastasis in RIP-Tag2 Transgenic Mice
- (2013) B. Sennino et al. CANCER RESEARCH
- Poly(lactic-co-glycolic) Acid-Controlled-Release Systems: Experimental and Modeling Insights
- (2013) Daniel J. Hines et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Efficient measurement of total tumor microvascularityex vivousing a mathematical model to optimize volume subsampling
- (2013) Bryan Q. Spring et al. JOURNAL OF BIOMEDICAL OPTICS
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
- (2013) C Hage et al. Cell Death & Disease
- In Vivo Targeted Deep-Tissue Photodynamic Therapy Based on Near-Infrared Light Triggered Upconversion Nanoconstruct
- (2012) Sisi Cui et al. ACS Nano
- Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
- (2012) Z. Cheng et al. SCIENCE
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
- (2011) Chenwei Li et al. GASTROENTEROLOGY
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents
- (2011) Jonathan F. Lovell et al. NATURE MATERIALS
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer
- (2010) I. Rizvi et al. CANCER RESEARCH
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Understanding biophysicochemical interactions at the nano–bio interface
- (2009) Andre E. Nel et al. NATURE MATERIALS
- Analysis of Variance
- (2008) Martin G. Larson CIRCULATION
- In vivo Optical Molecular Imaging of Vascular Endothelial Growth Factor for Monitoring Cancer Treatment
- (2008) S. K. Chang et al. CLINICAL CANCER RESEARCH
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now